Integra LifeSciences Holdings Corporation (IART)

IART Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	886	967	1,750	3,405	4,683	5,674
Market Cap Growth	-55.27%	-44.72%	-48.60%	-27.30%	-17.47%	3.71%
Enterprise Value	2,626	2,707	3,464	4,800	5,872	6,918
Last Close Price	11.38	12.42	22.68	43.55	56.07	66.99
PE Ratio	-	-	-	50.26	25.94	33.56
Forward PE	4.85	5.21	8.83	12.94	16.16	20.19
PS Ratio	0.54	0.59	1.09	2.21	3.01	3.68
PB Ratio	0.85	0.93	1.13	2.14	2.60	3.37
P/FCF Ratio	17.59	19.20	70.10	46.58	21.08	21.46
P/OCF Ratio	17.59	19.20	13.53	24.33	17.71	18.16
PEG Ratio	-	-	6.17	1.54	1.68	1.36
EV/Sales Ratio	1.61	1.66	2.15	3.11	3.77	4.49
EV/EBITDA Ratio	31.54	32.51	10.73	12.52	16.44	21.63
EV/EBIT Ratio	38.44	39.63	19.04	18.46	24.58	34.59
EV/FCF Ratio	52.12	53.73	138.75	65.68	26.44	26.16
Debt / Equity Ratio	1.94	1.94	1.29	1.06	0.90	1.01
Debt / EBITDA Ratio	24.11	24.11	5.72	4.13	4.25	5.00
Debt / FCF Ratio	39.85	39.85	79.57	23.03	7.27	6.43
Net Debt / Equity Ratio	1.68	1.68	1.11	0.87	0.64	0.70
Net Debt / EBITDA Ratio	20.89	20.89	5.31	3.58	3.24	3.71
Net Debt / FCF Ratio	34.53	34.53	68.61	18.80	5.22	4.49
Asset Turnover	-	-	0.41	0.40	0.41	0.42
Inventory Turnover	-	-	1.59	1.66	1.83	1.91
Quick Ratio	-	-	0.59	1.85	2.24	2.23
Current Ratio	-	-	1.17	3.45	3.62	3.39
Return on Equity (ROE)	-39.99%	-39.99%	-0.44%	3.99%	10.35%	10.57%
Return on Assets (ROA)	-	-	2.91%	4.24%	3.89%	3.38%
Return on Invested Capital (ROIC)	2.46%	2.26%	5.85%	7.33%	6.91%	5.56%
Return on Capital Employed (ROCE)	-	-	5.80%	7.50%	6.70%	5.80%
Earnings Yield	-58.27%	-53.39%	-0.40%	1.99%	3.86%	2.98%
FCF Yield	5.68%	5.21%	1.43%	2.15%	4.74%	4.66%
Buyback Yield / Dilution	0.44%	0.44%	4.14%	3.81%	2.30%	-0.30%

Updated Feb 26, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q